Sedana Medical Management
Management criteria checks 2/4
Sedana Medical's CEO is Johannes Doll, appointed in Oct 2021, has a tenure of 2.92 years. total yearly compensation is SEK5.24M, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth SEK2.74M. The average tenure of the management team and the board of directors is 2.4 years and 2.3 years respectively.
Key information
Johannes Doll
Chief executive officer
SEK 5.2m
Total compensation
| CEO salary percentage | 62.2% |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.4yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -SEK 41m |
| Mar 31 2024 | n/a | n/a | -SEK 23m |
| Dec 31 2023 | SEK 5m | SEK 3m | -SEK 60m |
| Sep 30 2023 | n/a | n/a | -SEK 57m |
| Jun 30 2023 | n/a | n/a | -SEK 58m |
| Mar 31 2023 | n/a | n/a | -SEK 71m |
| Dec 31 2022 | SEK 5m | SEK 3m | -SEK 74m |
| Sep 30 2022 | n/a | n/a | -SEK 54m |
| Jun 30 2022 | n/a | n/a | -SEK 62m |
| Mar 31 2022 | n/a | n/a | -SEK 68m |
| Dec 31 2021 | SEK 5m | SEK 1m | -SEK 58m |
Compensation vs Market: Johannes's total compensation ($USD512.74K) is below average for companies of similar size in the UK market ($USD770.39K).
Compensation vs Earnings: Johannes's compensation has increased whilst the company is unprofitable.
CEO
Johannes Doll (43 yo)
2.9yrs
Tenure
SEK 5,244,000
Compensation
Mr. Johannes Doll serves as Chief Executive Officer and President at Sedana Medical AB (publ) since October 01, 2021. Mr. Doll had been Executive Vice President and Chief Commercial Officer at Orexo AB (pu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 2.9yrs | SEK 5.24m | 0.12% SEK 2.7m | |
| Chief Financial Officer | 2.4yrs | no data | 0.12% SEK 2.7m | |
| General Counsel | 2.1yrs | no data | no data | |
| Chief Medical Officer | 6.7yrs | no data | 0.23% SEK 5.3m | |
| Head of Group Finance | no data | no data | no data | |
| Head of International Markets | 2.3yrs | no data | 0.0050% SEK 116.2k | |
| Chief Commercial Officer | less than a year | no data | no data | |
| VP of Regulatory Affairs and QA | 4.3yrs | no data | 0.00070% SEK 16.2k | |
| GM for Germany | 1.2yrs | no data | no data | |
| Supply Chain & Manufacturing Director | 3.5yrs | no data | 0.0056% SEK 130.3k |
2.4yrs
Average Tenure
47yo
Average Age
Experienced Management: SEDANS's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 3.3yrs | SEK 545.00k | no data | |
| Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 2.3yrs | SEK 242.00k | 0.0045% SEK 104.6k | |
| Independent Director | 4.3yrs | SEK 317.00k | 0.010% SEK 232.6k |
2.3yrs
Average Tenure
55yo
Average Age
Experienced Board: SEDANS's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/14 15:40 |
| End of Day Share Price | 2024/06/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sedana Medical AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Östling | Pareto Securities |
| Filip Wiberg | Pareto Securities |
| Oscar Bergman | Redeye |